160 related articles for article (PubMed ID: 22714536)
1. Structural insights into interacting mechanism of ID1 protein with an antagonist ID1/3-PA7 and agonist ETS-1 in treatment of ovarian cancer: molecular docking and dynamics studies.
Muthu K; Panneerselvam M; Jayaraman M; Topno NS; Das AA; Ramadas K
J Mol Model; 2012 Nov; 18(11):4865-84. PubMed ID: 22714536
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells.
Mern DS; Hasskarl J; Burwinkel B
Br J Cancer; 2010 Oct; 103(8):1237-44. PubMed ID: 20842131
[TBL] [Abstract][Full Text] [Related]
3. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
4. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
5. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas.
Polsky D; Young AZ; Busam KJ; Alani RM
Cancer Res; 2001 Aug; 61(16):6008-11. PubMed ID: 11507043
[TBL] [Abstract][Full Text] [Related]
6. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a.
Alani RM; Young AZ; Shifflett CB
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7812-6. PubMed ID: 11427735
[TBL] [Abstract][Full Text] [Related]
7. Bmi-1 reduction plays a key role in physiological and premature aging of primary human keratinocytes.
Cordisco S; Maurelli R; Bondanza S; Stefanini M; Zambruno G; Guerra L; Dellambra E
J Invest Dermatol; 2010 Apr; 130(4):1048-62. PubMed ID: 19907431
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cellular senescence and p16(INK4a) expression by Id1 and E47 proteins in human diploid fibroblast.
Zheng W; Wang H; Xue L; Zhang Z; Tong T
J Biol Chem; 2004 Jul; 279(30):31524-32. PubMed ID: 15138269
[TBL] [Abstract][Full Text] [Related]
9. The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media.
Hamajima Y; Komori M; Preciado DA; Choo DI; Moribe K; Murakami S; Ondrey FG; Lin J
Cell Prolif; 2010 Oct; 43(5):457-63. PubMed ID: 20887552
[TBL] [Abstract][Full Text] [Related]
10. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
Leong WF; Chau JF; Li B
Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
[TBL] [Abstract][Full Text] [Related]
11. ETS-dependent p16INK4a and p21waf1/cip1 gene expression upon endothelin-1 stimulation in malignant versus and non-malignant proximal tubule cells.
von Brandenstein M; Schlosser M; Richter C; Depping R; Fries JW
Life Sci; 2012 Oct; 91(13-14):562-71. PubMed ID: 22521293
[TBL] [Abstract][Full Text] [Related]
12. Expression of genes involved in the regulation of p16 in psoriatic involved skin.
Mark EB; Jonsson M; Asp J; Wennberg AM; Mölne L; Lindahl A
Arch Dermatol Res; 2006 Apr; 297(10):459-67. PubMed ID: 16552541
[TBL] [Abstract][Full Text] [Related]
13. Id1 overexpression is independent of repression and epigenetic silencing of tumor suppressor genes in melanoma.
Healey MA; Deaton SL; Alder JK; Winnepenninckx V; Casero RA; Herman JG
Epigenetics; 2010 Jul; 5(5):410-21. PubMed ID: 20484992
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.
Ohtani N; Zebedee Z; Huot TJ; Stinson JA; Sugimoto M; Ohashi Y; Sharrocks AD; Peters G; Hara E
Nature; 2001 Feb; 409(6823):1067-70. PubMed ID: 11234019
[TBL] [Abstract][Full Text] [Related]
15. p16
Al-Khalaf HH; Nallar SC; Kalvakolanu DV; Aboussekhra A
Mol Carcinog; 2017 Jul; 56(7):1687-1702. PubMed ID: 28218424
[TBL] [Abstract][Full Text] [Related]
16. ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib.
Niu LL; Cheng CL; Li MY; Yang SL; Hu BG; Chong CCN; Chan SL; Ren J; Chen GG; Lai PBS
Cell Death Dis; 2018 Aug; 9(9):852. PubMed ID: 30154433
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of MEOX1 and MEOX2 regulation of the cyclin dependent kinase inhibitors p21 and p16 in vascular endothelial cells.
Douville JM; Cheung DY; Herbert KL; Moffatt T; Wigle JT
PLoS One; 2011; 6(12):e29099. PubMed ID: 22206000
[TBL] [Abstract][Full Text] [Related]
18. Computational characterization of the binding mode between oncoprotein Ets-1 and DNA-repair enzymes.
de Ruyck J; Brysbaert G; Villeret V; Aumercier M; Lensink MF
Proteins; 2018 Oct; 86(10):1055-1063. PubMed ID: 30019773
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional Regulation of the p16 Tumor Suppressor Gene.
Kotake Y; Naemura M; Murasaki C; Inoue Y; Okamoto H
Anticancer Res; 2015 Aug; 35(8):4397-401. PubMed ID: 26168478
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of the inhibition of Cdk4 and Cdk6 by p16(INK4a) through molecular dynamics simulations.
Villacañas O; Pérez JJ; Rubio-Martínez J
J Biomol Struct Dyn; 2002 Dec; 20(3):347-58. PubMed ID: 12437373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
